BEGIN:VCALENDAR VERSION:2.0 PRODID:-//Dupixent Discussions - ECPv6.15.20//NONSGML v1.0//EN CALSCALE:GREGORIAN METHOD:PUBLISH X-ORIGINAL-URL:https://www.dupixentdiscussions.com X-WR-CALDESC:Events for Dupixent Discussions REFRESH-INTERVAL;VALUE=DURATION:PT1H X-Robots-Tag:noindex X-PUBLISHED-TTL:PT1H BEGIN:VTIMEZONE TZID:America/New_York BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20240310T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20241103T060000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20250309T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20251102T060000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20260308T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20261101T060000 END:STANDARD END:VTIMEZONE BEGIN:VTIMEZONE TZID:America/Chicago BEGIN:DAYLIGHT TZOFFSETFROM:-0600 TZOFFSETTO:-0500 TZNAME:CDT DTSTART:20240310T080000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0500 TZOFFSETTO:-0600 TZNAME:CST DTSTART:20241103T070000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0600 TZOFFSETTO:-0500 TZNAME:CDT DTSTART:20250309T080000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0500 TZOFFSETTO:-0600 TZNAME:CST DTSTART:20251102T070000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0600 TZOFFSETTO:-0500 TZNAME:CDT DTSTART:20260308T080000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0500 TZOFFSETTO:-0600 TZNAME:CST DTSTART:20261101T070000 END:STANDARD END:VTIMEZONE BEGIN:VTIMEZONE TZID:America/Los_Angeles BEGIN:DAYLIGHT TZOFFSETFROM:-0800 TZOFFSETTO:-0700 TZNAME:PDT DTSTART:20240310T100000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0700 TZOFFSETTO:-0800 TZNAME:PST DTSTART:20241103T090000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0800 TZOFFSETTO:-0700 TZNAME:PDT DTSTART:20250309T100000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0700 TZOFFSETTO:-0800 TZNAME:PST DTSTART:20251102T090000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0800 TZOFFSETTO:-0700 TZNAME:PDT DTSTART:20260308T100000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0700 TZOFFSETTO:-0800 TZNAME:PST DTSTART:20261101T090000 END:STANDARD END:VTIMEZONE BEGIN:VEVENT DTSTART;TZID=America/New_York:20251112T121500 DTEND;TZID=America/New_York:20251112T131500 DTSTAMP:20260410T105751 CREATED:20250829T203328Z LAST-MODIFIED:20250924T200016Z UID:10000745-1762949700-1762953300@www.dupixentdiscussions.com SUMMARY:DUPIXENT@(dupilumab) Patient Story followed by A Treatment Option for Appropriate Patients with Certain Skin Diseases Driven in Part by Type 2 Inflammation by Sandri Johnson\, NP DESCRIPTION:Join us for a virtual discussion with an expert speaker and an adult patient with prurigo nodularis (PN) to Learn more about a treatment option that may help appropriate patients with certain skin diseases driven in part by Type 2 inflammation\n\n \n \n Attendee Registration\n \n \n LinkedInThis field is for validation purposes and should be left unchanged.confirmationThis field is hidden when viewing the formtopicThis field is hidden when viewing the formDescription1This field is hidden when viewing the formDescription2This field is hidden when viewing the formspeakerThis field is hidden when viewing the formEvent TimeThis field is hidden when viewing the formEvent Time EndThis field is hidden when viewing the formEvent ReminderThis field is hidden when viewing the formEvent DateThis field is hidden when viewing the formWritten DateThis field is hidden when viewing the formGoogle DateThis field is hidden when viewing the formDate\n \n MM slash DD slash YYYY\n \n This field is hidden when viewing the formTime\n \n \n Hours\n \n :\n \n \n Minutes\n \n \n \n \n AM\n PM\n \n AM/PM \n \n Name(Required)\n \n \n \n First\n \n \n \n \n Last\n \n \n Email(Required)\n \n \n Enter Email\n \n \n \n Confirm Email\n \n \n Professional Designation(Required)Medical AssistantNurseNurse PractitionerNon-HCPPhysicianPhysician AssistantPharmacyIndustry ProfessionalResidentCredentials(Required)APRNDOMDPANPPharmDPhDRNResidentOtherCredentials (if you selected "other")(Required)Specialty(Required)DermatologyAllergyMDPrimary CareInternal MedicineEmergency MedicineNot ApplicableOtherSpecialty (if you selected "other")(Required)Hospital/Industry Affiliation(Required)Location(Required) \n \n \n \n Street Address\n \n \n Address Line 2\n \n \n City\n \n \n State / Province / Region\n \n \n ZIP / Postal Code\n \n AfghanistanAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBonaire\, Sint Eustatius and SabaBosnia and HerzegovinaBotswanaBouvet IslandBrazilBritish Indian Ocean TerritoryBrunei DarussalamBulgariaBurkina FasoBurundiCabo VerdeCambodiaCameroonCanadaCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos IslandsColombiaComorosCongoCongo\, Democratic Republic of theCook IslandsCosta RicaCroatiaCubaCuraçaoCyprusCzechiaCôte d'IvoireDenmarkDjiboutiDominicaDominican RepublicEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEswatiniEthiopiaFalkland IslandsFaroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHeard Island and McDonald IslandsHoly SeeHondurasHong KongHungaryIcelandIndiaIndonesiaIranIraqIrelandIsle of ManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKorea\, Democratic People's Republic ofKorea\, Republic ofKuwaitKyrgyzstanLao People's Democratic RepublicLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacaoMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorth MacedoniaNorthern Mariana IslandsNorwayOmanPakistanPalauPalestine\, State ofPanamaPapua New GuineaParaguayPeruPhilippinesPitcairnPolandPortugalPuerto RicoQatarRomaniaRussian FederationRwandaRéunionSaint BarthélemySaint Helena\, Ascension and Tristan da CunhaSaint Kitts and NevisSaint LuciaSaint MartinSaint Pierre and MiquelonSaint Vincent and the GrenadinesSamoaSan MarinoSao Tome and PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSint MaartenSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth Georgia and the South Sandwich IslandsSouth SudanSpainSri LankaSudanSurinameSvalbard and Jan MayenSwedenSwitzerlandSyria Arab RepublicTaiwanTajikistanTanzania\, the United Republic ofThailandTimor-LesteTogoTokelauTongaTrinidad and TobagoTunisiaTurkmenistanTurks and Caicos IslandsTuvaluTürkiyeUS Minor Outlying IslandsUgandaUkraineUnited Arab EmiratesUnited KingdomUnited StatesUruguayUzbekistanVanuatuVenezuelaViet NamVirgin Islands\, BritishVirgin Islands\, U.S.Wallis and FutunaWestern SaharaYemenZambiaZimbabweÅland Islands\n Country\n \n \n Are you registering on behalf of(Required)myselfoffice/ other groupchild programAre you a prescriber?\n \n Yes\n \n \n No\n NPI NumberOffice SpecialtyTotal Number of Planned AttendeesPrivacy Policy(Required) I attest that I have reviewed the Sanofi Privacy Policy and Regeneron Privacy Policy notices. URL:https://www.dupixentdiscussions.com/event/dupixent%c2%a8-dupilumab-patient-story-followed-by-a-treatment-option-for-appropriate-patients-with-certain-skin-diseases-driven-in-part-by-type-2-inflammation-by-sandri-johnson-np/ LOCATION:Virtual (Zoom) CATEGORIES:Prurigo Nodularis (PN) ATTACH;FMTTYPE=image/png:https://www.dupixentdiscussions.com/wp-content/uploads/2025/08/Sandri-Johnson-NP-1jMtM8.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Chicago:20251103T121500 DTEND;TZID=America/Chicago:20251103T131500 DTSTAMP:20260410T105751 CREATED:20250829T203315Z LAST-MODIFIED:20250924T195938Z UID:10000737-1762172100-1762175700@www.dupixentdiscussions.com SUMMARY:DUPIXENT@ (dupilumab) Patient Story followed by A Treatment Option for Appropriate Patients with Certain Skin Diseases Driven in Part by Type 2 Inflammation by Omar Noor\, MD DESCRIPTION:Join us for a virtual discussion with an expert speaker and an adult patient with prurigo nodularis (PN) to Learn more about a treatment option that may help appropriate patients with certain skin diseases driven in part by Type 2 inflammation\n \n \n Attendee Registration\n \n \n FacebookThis field is for validation purposes and should be left unchanged.confirmationThis field is hidden when viewing the formtopicThis field is hidden when viewing the formDescription1This field is hidden when viewing the formDescription2This field is hidden when viewing the formspeakerThis field is hidden when viewing the formEvent TimeThis field is hidden when viewing the formEvent Time EndThis field is hidden when viewing the formEvent ReminderThis field is hidden when viewing the formEvent DateThis field is hidden when viewing the formWritten DateThis field is hidden when viewing the formGoogle DateThis field is hidden when viewing the formDate\n \n MM slash DD slash YYYY\n \n This field is hidden when viewing the formTime\n \n \n Hours\n \n :\n \n \n Minutes\n \n \n \n \n AM\n PM\n \n AM/PM \n \n Name(Required)\n \n \n \n First\n \n \n \n \n Last\n \n \n Email(Required)\n \n \n Enter Email\n \n \n \n Confirm Email\n \n \n Professional Designation(Required)Medical AssistantNurseNurse PractitionerNon-HCPPhysicianPhysician AssistantPharmacyIndustry ProfessionalResidentCredentials(Required)APRNDOMDPANPPharmDPhDRNResidentOtherCredentials (if you selected "other")(Required)Specialty(Required)DermatologyAllergyMDPrimary CareInternal MedicineEmergency MedicineNot ApplicableOtherSpecialty (if you selected "other")(Required)Hospital/Industry Affiliation(Required)Location(Required) \n \n \n \n Street Address\n \n \n Address Line 2\n \n \n City\n \n \n State / Province / Region\n \n \n ZIP / Postal Code\n \n AfghanistanAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBonaire\, Sint Eustatius and SabaBosnia and HerzegovinaBotswanaBouvet IslandBrazilBritish Indian Ocean TerritoryBrunei DarussalamBulgariaBurkina FasoBurundiCabo VerdeCambodiaCameroonCanadaCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos IslandsColombiaComorosCongoCongo\, Democratic Republic of theCook IslandsCosta RicaCroatiaCubaCuraçaoCyprusCzechiaCôte d'IvoireDenmarkDjiboutiDominicaDominican RepublicEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEswatiniEthiopiaFalkland IslandsFaroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHeard Island and McDonald IslandsHoly SeeHondurasHong KongHungaryIcelandIndiaIndonesiaIranIraqIrelandIsle of ManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKorea\, Democratic People's Republic ofKorea\, Republic ofKuwaitKyrgyzstanLao People's Democratic RepublicLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacaoMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorth MacedoniaNorthern Mariana IslandsNorwayOmanPakistanPalauPalestine\, State ofPanamaPapua New GuineaParaguayPeruPhilippinesPitcairnPolandPortugalPuerto RicoQatarRomaniaRussian FederationRwandaRéunionSaint BarthélemySaint Helena\, Ascension and Tristan da CunhaSaint Kitts and NevisSaint LuciaSaint MartinSaint Pierre and MiquelonSaint Vincent and the GrenadinesSamoaSan MarinoSao Tome and PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSint MaartenSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth Georgia and the South Sandwich IslandsSouth SudanSpainSri LankaSudanSurinameSvalbard and Jan MayenSwedenSwitzerlandSyria Arab RepublicTaiwanTajikistanTanzania\, the United Republic ofThailandTimor-LesteTogoTokelauTongaTrinidad and TobagoTunisiaTurkmenistanTurks and Caicos IslandsTuvaluTürkiyeUS Minor Outlying IslandsUgandaUkraineUnited Arab EmiratesUnited KingdomUnited StatesUruguayUzbekistanVanuatuVenezuelaViet NamVirgin Islands\, BritishVirgin Islands\, U.S.Wallis and FutunaWestern SaharaYemenZambiaZimbabweÅland Islands\n Country\n \n \n Are you registering on behalf of(Required)myselfoffice/ other groupchild programAre you a prescriber?\n \n Yes\n \n \n No\n NPI NumberOffice SpecialtyTotal Number of Planned AttendeesPrivacy Policy(Required) I attest that I have reviewed the Sanofi Privacy Policy and Regeneron Privacy Policy notices. URL:https://www.dupixentdiscussions.com/event/dupixent%c2%a8-dupilumab-patient-story-followed-by-a-treatment-option-for-appropriate-patients-with-certain-skin-diseases-driven-in-part-by-type-2-inflammation-by-omar-noor-md/ LOCATION:Virtual (Zoom) CATEGORIES:Prurigo Nodularis (PN) ATTACH;FMTTYPE=image/png:https://www.dupixentdiscussions.com/wp-content/uploads/2025/08/Omar-Noor-MD-is4bst.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20251022T121500 DTEND;TZID=America/Los_Angeles:20251022T131500 DTSTAMP:20260410T105751 CREATED:20250829T203311Z LAST-MODIFIED:20250924T195827Z UID:10000729-1761135300-1761138900@www.dupixentdiscussions.com SUMMARY:DUPIXENT@ (dupilumab) Patient Story followed by A Treatment Option for Appropriate Patients with Certain Skin Diseases Driven in Part by Type 2 Inflammation by Zakiya Rice\, MD DESCRIPTION:Join us for a virtual discussion with an expert speaker and an adult patient with prurigo nodularis (PN) to Learn more about a treatment option that may help appropriate patients with certain skin diseases driven in part by Type 2 inflammation\n \n \n Attendee Registration\n \n \n LinkedInThis field is for validation purposes and should be left unchanged.confirmationThis field is hidden when viewing the formtopicThis field is hidden when viewing the formDescription1This field is hidden when viewing the formDescription2This field is hidden when viewing the formspeakerThis field is hidden when viewing the formEvent TimeThis field is hidden when viewing the formEvent Time EndThis field is hidden when viewing the formEvent ReminderThis field is hidden when viewing the formEvent DateThis field is hidden when viewing the formWritten DateThis field is hidden when viewing the formGoogle DateThis field is hidden when viewing the formDate\n \n MM slash DD slash YYYY\n \n This field is hidden when viewing the formTime\n \n \n Hours\n \n :\n \n \n Minutes\n \n \n \n \n AM\n PM\n \n AM/PM \n \n Name(Required)\n \n \n \n First\n \n \n \n \n Last\n \n \n Email(Required)\n \n \n Enter Email\n \n \n \n Confirm Email\n \n \n Professional Designation(Required)Medical AssistantNurseNurse PractitionerNon-HCPPhysicianPhysician AssistantPharmacyIndustry ProfessionalResidentCredentials(Required)APRNDOMDPANPPharmDPhDRNResidentOtherCredentials (if you selected "other")(Required)Specialty(Required)DermatologyAllergyMDPrimary CareInternal MedicineEmergency MedicineNot ApplicableOtherSpecialty (if you selected "other")(Required)Hospital/Industry Affiliation(Required)Location(Required) \n \n \n \n Street Address\n \n \n Address Line 2\n \n \n City\n \n \n State / Province / Region\n \n \n ZIP / Postal Code\n \n AfghanistanAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBonaire\, Sint Eustatius and SabaBosnia and HerzegovinaBotswanaBouvet IslandBrazilBritish Indian Ocean TerritoryBrunei DarussalamBulgariaBurkina FasoBurundiCabo VerdeCambodiaCameroonCanadaCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos IslandsColombiaComorosCongoCongo\, Democratic Republic of theCook IslandsCosta RicaCroatiaCubaCuraçaoCyprusCzechiaCôte d'IvoireDenmarkDjiboutiDominicaDominican RepublicEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEswatiniEthiopiaFalkland IslandsFaroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHeard Island and McDonald IslandsHoly SeeHondurasHong KongHungaryIcelandIndiaIndonesiaIranIraqIrelandIsle of ManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKorea\, Democratic People's Republic ofKorea\, Republic ofKuwaitKyrgyzstanLao People's Democratic RepublicLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacaoMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorth MacedoniaNorthern Mariana IslandsNorwayOmanPakistanPalauPalestine\, State ofPanamaPapua New GuineaParaguayPeruPhilippinesPitcairnPolandPortugalPuerto RicoQatarRomaniaRussian FederationRwandaRéunionSaint BarthélemySaint Helena\, Ascension and Tristan da CunhaSaint Kitts and NevisSaint LuciaSaint MartinSaint Pierre and MiquelonSaint Vincent and the GrenadinesSamoaSan MarinoSao Tome and PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSint MaartenSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth Georgia and the South Sandwich IslandsSouth SudanSpainSri LankaSudanSurinameSvalbard and Jan MayenSwedenSwitzerlandSyria Arab RepublicTaiwanTajikistanTanzania\, the United Republic ofThailandTimor-LesteTogoTokelauTongaTrinidad and TobagoTunisiaTurkmenistanTurks and Caicos IslandsTuvaluTürkiyeUS Minor Outlying IslandsUgandaUkraineUnited Arab EmiratesUnited KingdomUnited StatesUruguayUzbekistanVanuatuVenezuelaViet NamVirgin Islands\, BritishVirgin Islands\, U.S.Wallis and FutunaWestern SaharaYemenZambiaZimbabweÅland Islands\n Country\n \n \n Are you registering on behalf of(Required)myselfoffice/ other groupchild programAre you a prescriber?\n \n Yes\n \n \n No\n NPI NumberOffice SpecialtyTotal Number of Planned AttendeesPrivacy Policy(Required) I attest that I have reviewed the Sanofi Privacy Policy and Regeneron Privacy Policy notices. URL:https://www.dupixentdiscussions.com/event/dupixent%c2%a8-dupilumab-patient-story-followed-by-a-treatment-option-for-appropriate-patients-with-certain-skin-diseases-driven-in-part-by-type-2-inflammation-by-zakiya-rice-md/ LOCATION:Virtual (Zoom) CATEGORIES:Prurigo Nodularis (PN) ATTACH;FMTTYPE=image/png:https://www.dupixentdiscussions.com/wp-content/uploads/2025/08/Zakiya-Rice-MD-9UKcCE.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20251016T121500 DTEND;TZID=America/New_York:20251016T131500 DTSTAMP:20260410T105751 CREATED:20250829T203308Z LAST-MODIFIED:20250919T211325Z UID:10000724-1760616900-1760620500@www.dupixentdiscussions.com SUMMARY:Clinical Case Discussion: An Adult Patient with Prurigo Nodularis and a Treatment Option for Appropriate Patients 18+ Years of Age by Michael Payette\, MD DESCRIPTION:Join us for a program discussing a real-world case of an adult patient with prurigo nodularis (PN) and a treatment option that may help appropriate patients.\n \n \n Attendee Registration\n \n \n CommentsThis field is for validation purposes and should be left unchanged.confirmationThis field is hidden when viewing the formtopicThis field is hidden when viewing the formDescription1This field is hidden when viewing the formDescription2This field is hidden when viewing the formspeakerThis field is hidden when viewing the formEvent TimeThis field is hidden when viewing the formEvent Time EndThis field is hidden when viewing the formEvent ReminderThis field is hidden when viewing the formEvent DateThis field is hidden when viewing the formWritten DateThis field is hidden when viewing the formGoogle DateThis field is hidden when viewing the formDate\n \n MM slash DD slash YYYY\n \n This field is hidden when viewing the formTime\n \n \n Hours\n \n :\n \n \n Minutes\n \n \n \n \n AM\n PM\n \n AM/PM \n \n Name(Required)\n \n \n \n First\n \n \n \n \n Last\n \n \n Email(Required)\n \n \n Enter Email\n \n \n \n Confirm Email\n \n \n Professional Designation(Required)Medical AssistantNurseNurse PractitionerNon-HCPPhysicianPhysician AssistantPharmacyIndustry ProfessionalResidentCredentials(Required)APRNDOMDPANPPharmDPhDRNResidentOtherCredentials (if you selected "other")(Required)Specialty(Required)DermatologyAllergyMDPrimary CareInternal MedicineEmergency MedicineNot ApplicableOtherSpecialty (if you selected "other")(Required)Hospital/Industry Affiliation(Required)Location(Required) \n \n \n \n Street Address\n \n \n Address Line 2\n \n \n City\n \n \n State / Province / Region\n \n \n ZIP / Postal Code\n \n AfghanistanAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBonaire\, Sint Eustatius and SabaBosnia and HerzegovinaBotswanaBouvet IslandBrazilBritish Indian Ocean TerritoryBrunei DarussalamBulgariaBurkina FasoBurundiCabo VerdeCambodiaCameroonCanadaCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos IslandsColombiaComorosCongoCongo\, Democratic Republic of theCook IslandsCosta RicaCroatiaCubaCuraçaoCyprusCzechiaCôte d'IvoireDenmarkDjiboutiDominicaDominican RepublicEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEswatiniEthiopiaFalkland IslandsFaroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHeard Island and McDonald IslandsHoly SeeHondurasHong KongHungaryIcelandIndiaIndonesiaIranIraqIrelandIsle of ManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKorea\, Democratic People's Republic ofKorea\, Republic ofKuwaitKyrgyzstanLao People's Democratic RepublicLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacaoMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorth MacedoniaNorthern Mariana IslandsNorwayOmanPakistanPalauPalestine\, State ofPanamaPapua New GuineaParaguayPeruPhilippinesPitcairnPolandPortugalPuerto RicoQatarRomaniaRussian FederationRwandaRéunionSaint BarthélemySaint Helena\, Ascension and Tristan da CunhaSaint Kitts and NevisSaint LuciaSaint MartinSaint Pierre and MiquelonSaint Vincent and the GrenadinesSamoaSan MarinoSao Tome and PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSint MaartenSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth Georgia and the South Sandwich IslandsSouth SudanSpainSri LankaSudanSurinameSvalbard and Jan MayenSwedenSwitzerlandSyria Arab RepublicTaiwanTajikistanTanzania\, the United Republic ofThailandTimor-LesteTogoTokelauTongaTrinidad and TobagoTunisiaTurkmenistanTurks and Caicos IslandsTuvaluTürkiyeUS Minor Outlying IslandsUgandaUkraineUnited Arab EmiratesUnited KingdomUnited StatesUruguayUzbekistanVanuatuVenezuelaViet NamVirgin Islands\, BritishVirgin Islands\, U.S.Wallis and FutunaWestern SaharaYemenZambiaZimbabweÅland Islands\n Country\n \n \n Are you registering on behalf of(Required)myselfoffice/ other groupchild programAre you a prescriber?\n \n Yes\n \n \n No\n NPI NumberOffice SpecialtyTotal Number of Planned AttendeesPrivacy Policy(Required) I attest that I have reviewed the Sanofi Privacy Policy and Regeneron Privacy Policy notices. URL:https://www.dupixentdiscussions.com/event/clinical-case-discussion-a-62-year-old-female-with-itchy-skin-lesions-could-it-be-pn-by-michael-payette-md/ LOCATION:Virtual (Zoom) CATEGORIES:Prurigo Nodularis (PN) ATTACH;FMTTYPE=image/png:https://www.dupixentdiscussions.com/wp-content/uploads/2025/06/Michael-Payette-MD.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20251008T121500 DTEND;TZID=America/New_York:20251008T124500 DTSTAMP:20260410T105751 CREATED:20250829T203301Z LAST-MODIFIED:20250926T005312Z UID:10000719-1759925700-1759927500@www.dupixentdiscussions.com SUMMARY:A Treatment Option for Appropriate Patients with Certain Skin Diseases Driven in Part by Type 2 Inflammation by Gina Mangin\, PA-C DESCRIPTION:This program is being held in partnership with SDPA. Please visit the link below to be taken to the registration page for this program. \nRegister \n  URL:https://www.dupixentdiscussions.com/event/a-treatment-option-for-appropriate-patients-with-skin-diseases-driven-in-part-by-type-2-inflammation-by-gina-mangin-pa-c/ LOCATION:Virtual (Zoom) CATEGORIES:Prurigo Nodularis (PN) ATTACH;FMTTYPE=image/png:https://www.dupixentdiscussions.com/wp-content/uploads/2025/06/Gina-Mangin-PA-C.png END:VEVENT END:VCALENDAR